Similar to other E2F target genes, as we and others have previously shown [5, 6, 31, 32], we here find that CENPI overexpression promotes CIN, which facilitates tumor development and drug resistance in a variety of ways [1, 2]. The gene discussed is CENPI; the disease is neoplasm.